Furosemide

ANDA 74337, held by Hospira. Furosemide.

As of Nov 13, 2026, ANDA 74337 (Furosemide), held by Hospira, was first approved by FDA on Oct 31, 1994, with 1 approved supplement and 0 published complete response letters.

First approved: Oct 31, 1994
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Oct 31, 1994	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Furosemide10MG/ML · injectable;injection	Furosemide	Discontinued

All 2 submissions, including labeling and manufacturing supplements

Date	Submission	Status	Documents
Aug 12, 1997	Supplement 1Labeling	Approved	None posted
Oct 31, 1994	Original application	Approved	None posted

Identifiers

Application: ANDA 74337
Drugs@FDA: Overview at FDA
Company: Hospira

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters